CTOs on the Move

Median Technologies

www.mediantechnologies.com

 
Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. As The Imaging Phenomics Company®, Median provides insights into novel therapies and treatment strategies. Our unique solutions, MediScan® for lesion management in patient care, Lesion Management Solution (LMS) for lesion detection, measurement and reporting in clinical trials, and our imaging phenotyping system iBiopsy®, together with our global team of experts, are advancing the development of new drugs and diagnostic tools to monitor disease and assess response to therapy. Median Technologies supports biopharmaceutical sponsors and healthcare professionals around the world in bringing new and targeted treatments to patients ...
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Peter Bannister
Chief Technology Officer Profile

Similar Companies

Nemcomed

Nemcomed is a Hicksville, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ancora Heart

We are a medical device company based in Santa Clara, CA, dedicated to helping people with heart failure and functional mitral regurgitation (FMR) feel better and live longer.

MicroVision

MicroVision is a Seabrook, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

GlucoTrack

GlucoTrack, Inc (formerly known as Integrity Applications, Inc.) is focused on the design, development, and commercialization of novel technologies for people with diabetes and prediabetes. The Company`s initial product, GlucoTrack®, is a proprietary non-invasive glucose monitoring device designed to obtain glucose level measurements without the pain, incremental cost, difficulty, or discomfort of conventional invasive finger stick devices.

Still River Systems, Inc.

Still River Systems is dedicated to providing physicians and their patients access to high quality, cost-effective proton therapy solutions, and to helping establish this superior treatment modality as a standard of care for patients worldwide.